|1.||Topçu, I: 1 article (08/2010)|
|2.||Ekici, Z: 1 article (08/2010)|
|3.||Keleş, G T: 1 article (08/2010)|
|4.||Yentür, A: 1 article (08/2010)|
|5.||Chu, H-Y: 1 article (10/2008)|
|6.||Chang, C-C: 1 article (10/2008)|
|7.||Chen, L-C: 1 article (10/2008)|
|8.||Chang, S-T: 1 article (10/2008)|
|9.||Tsai, K-C: 1 article (10/2008)|
|10.||Turcani, P: 1 article (01/2002)|
08/01/2010 - "The preemptive analgesic efficacy and adverse effects of preoperatively administered piroxicam-beta-cyclodextrin for post-endoscopic sinus surgery pain was determined in a prospective, double-blind, randomized, clinical study. "
01/01/1993 - "In view of its efficacy, tolerability and rapid onset of action, piroxicam-beta-cyclodextrin appears to be an useful analgesic and a prominent progress in the treatment of acute rheumatic pain."
12/01/1994 - "When rapid analgesia is required in the initial treatment of acute pain, the faster onset of action of piroxicam-beta-cyclodextrin may be an advantage over the parent compound; however, this is unlikely to be important during long term therapy. "
10/01/2008 - "The clinical effects of piroxicam-beta-cyclodextrin (PBC) in sachet form have been surveyed in patients with osteoarthritic or acute pain in western countries, but scarcely studied in those with chronic low back pain (LBP), and never investigated in the field of postural sway. "
12/01/1994 - "Thus, piroxicam-beta-cyclodextrin is an effective agent in patients with rheumatic diseases or other pain states. "
01/01/1993 - "The more rapid rise in piroxicam plasma concentrations and the reduced contact time of piroxicam in the upper gastrointestinal-tract may be reasons for the reduced incidence of gastrointestinal complaints and gastrointestinal bleeding and the rapid attainment of pain relief with piroxicam beta-cyclodextrin. "
|3.||Back Pain (Backache)
|5.||Migraine Disorders (Migraine)
09/01/1994 - "Piroxicam-beta-cyclodextrin in induced migraine attacks: a SPECT study with Tc-99m HM-PAO split-dose method."
09/01/1994 - "To verify the effect of piroxicam-beta-cyclodextrin (P-B-CD), a novel non-steroidal anti-inflammatory compound, on regional cerebral blood flow (rCBF) during migraine attacks, 7 female patients (mean age: 37.4 years), suffering from migraine without aura, were studied. "
|2.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|4.||Meclofenamic Acid (Meclofenamate)
|1.||Oral Surgery (Maxillofacial Surgery)